AMEH Company Profile and Key Details

Q: Who are the executives of AMEH?

Mr. Chandan BashoChief Strategy Officer, Interim Chief Financial Officer & Corporation Sec.Dr. Thomas S. Lam M.D., M.P.H.Pres, Co-Chief Executive Officer & DirectorMr. Neil AhujaPres of Provider SolutionsYubin ParkChief Analytics OfficerDr. WaiChow Young M.D.Chief Admin. OfficerMr. John VongChief Accounting OfficerMr. Chan BashoChief Strategy Officer & Interim Chief Financial OfficerMr. Brandon SimCo-Chief Executive OfficerDr. Jeremy R. Jackson M.D.Chief Quality OfficerDr. Carlos Palacios M.D.Chief Medical Officer for TexasDr. Kenneth T. Sim M.D.Executive Chairman

NASDAQ : AMEH

Apollo Medical

$40.82

-0.88-2.11%

Open: 4:00 PM

Not Actively Trading

68.43

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Apollo Medical Holdings, Inc. (AMEH) stock declined over -2.11%, trading at $40.82 on NASDAQ, down from the previous close of $41.70. The stock opened at $41.70, fluctuating between $40.71 and $42.75 in the recent session.

Stock Snapshot

41.7

Prev. Close

1.83B

Market Cap

40.71

Day Low

39.25

P/E Ratio

1.04

EPS (TTM)

2.4

Cash Flow per Share

41.7

Open

44.84M

Number of Shares

42.75

Day High

76.25%

Free Float in %

12.76

Book Value

313.94K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 22, 2024	41.02	41.11	39.51	39.67	106.55K
Mar 21, 2024	41.82	42.44	40.57	40.92	141.28K
Mar 20, 2024	39.75	42.16	39.57	41.55	124.81K
Mar 19, 2024	39.54	40.67	39.37	39.97	101.5K
Mar 18, 2024	39.91	40.41	39.42	39.57	113.74K
Mar 15, 2024	39.65	40.64	39.49	39.88	360.87K
Mar 14, 2024	40.51	40.92	39.50	40.09	180.45K
Mar 13, 2024	41.86	42.74	40.62	41.00	123.93K
Mar 12, 2024	42.11	42.58	41.60	42.04	107.54K
Mar 11, 2024	44.73	44.97	42.00	42.21	244.84K
Mar 08, 2024	45.05	45.71	44.47	44.72	227.85K
Mar 07, 2024	43.61	45.39	43.61	44.71	185.45K
Mar 06, 2024	43.50	44.24	43.10	43.82	118.8K
Mar 05, 2024	43.68	44.26	42.70	43.22	147.49K
Mar 04, 2024	44.33	44.90	43.35	43.97	162.9K
Mar 01, 2024	45.00	45.24	43.02	43.57	184.96K
Feb 29, 2024	44.16	45.48	44.16	45.04	292.48K
Feb 28, 2024	44.35	45.32	41.30	43.77	262.42K
Feb 27, 2024	42.46	43.86	41.11	43.54	378.26K
Feb 26, 2024	42.21	43.87	42.01	42.79	273.94K

Contact Details

Alhambra, CA 91801

United States

https://www.apollomed.net 626 282 0288

About Company

Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.

Stock Peers

ENSG

4.44+2.51%

The Ensign Group, Inc.$181.39 ADUS

0.75+0.67%

Addus HomeCare Corporation$112.82 FSHCX

0.37001+0.36%

Health Care Services Portfolio$103.02 AMED

0.01+0.01%

Amedisys, Inc.$100.99 OPCH

0.1+0.31%

Option Care Health, Inc.$32.51 MCTA

1.855+6.75%

Charming Medical Limited Class A Ordinary Shares$29.36 PNTG

-0.02-0.07%

The Pennant Group, Inc.$29.34 ASTH

0.66+2.84%

Astrana Health, Inc.$23.87 HCSG

0.37+1.93%

Healthcare Services Group, Inc.$19.54 KDLYW

2.995+19.14%

Kindly MD, Inc.$18.65

Company Overview

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) closed at $40.82 USD, losing -$0.88 (-2.11%) from the previous close of $41.70. The stock is currently mid-range between its 52-week high and low $28.86 and $45.71. With a market capitalization of about $1.83 billion, Apollo Medical Holdings, Inc. is classified as a small-cap and shows market-like volatility (beta ~1.04). Key stats such as the average daily volume over the past year has been around 208.84 thousand shares, trading with heavier-than-usual volume. Headquartered in Alhambra, CA, Apollo Medical Holdings, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Brandon Sim, the company employs approximately 1,362 people and listed since March 11, 2009. Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services.

Technical Performance

AMEH has shown sold momentum, gaining 6.27% over the past week and 13.86% over the past quarter, though year-to-date performance is up 1.85%. Short-term trend indicators are bearishly aligned (SMA20 10.26%, SMA50 10.44%, SMA200 19.58%). The stock’s 14-day RSI is 62.68 (firm momentum), while the ATR of 1.64 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -5.33% below its high and over 41.42% above its low.

Valuation Metrics

Apollo Medical Holdings, Inc. trades at a P/E ratio of 211.29, slightly above the S&P 500 average, with a price-to-sales ratio of 0.57 and a price-to-book ratio of 2.5 suggesting the stock is closer to book value. The P/FCF stands at 14.39, also above market averages.

Dividend & Fair Value

Apollo Medical Holdings, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $90.79. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Apollo Medical Holdings, Inc. generated EPS of $0.98 over the past year. Five-year average earnings growth is 1.93%. Wall Street analysts project EPS growth of 10.7% annually over the next five years. The latest quarter delivered EPS of $0.02. The next quarter is forecast at $0.14. Next year's EPS is expected at $15.96. Apollo Medical Holdings, Inc. earnings surprise history is a mixed track record. The quarter that ended February 27, 2024, missed forecasts by -88.24%. The prior quarter beat by 74.07%. Over the last six quarters, Apple has recorded several small beats. These include -77.78% in February 23, 2023.

Financial & Profitability Overview

Over the trailing twelve months, Apollo Medical generated $1.14B in revenue, or $24.95 per share. Gross margin was 16.99%, operating margin 9.16%, and net profit margin 4.31%. Returns are modest, with ROA at 5.09% and ROE at 8.87%.
On valuation metrics, Apollo Medical trades at a P/E of 211.29, P/S of 0.57 and P/B of 2.50. The current ratio is 1.40 and quick ratio is 1.40. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 49.54 days. Debt-to-equity is 0.11, supported by a cash flow-to-debt ratio of 1.42.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2022, Apollo Medical posted revenue of $1.14B, down slightly from $767.37M in the prior quarter. Gross profit was $193.31M (margin 16.99%). Operating income was $104.27M (margin 9.2%). Net income was$49.05M (EPS $1.09).
The company ended the quarter with $293.59M in cash and short-term investments, a total debt of $229.36M, and net debt of - $58.66M. Total assets were $963.91M, with equity of $0.00. Financials further reflected stability, with operating cash flow of $82.13M, free cash flow of $59.19M, and capital expenditures of - $22.94M.

Price Forecast & Outlook

Our AI price prediction model suggests that Apollo Medical Holdings, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -7.97%, with price expected at $36.51 by April 05, 2024, within a range of $35.13 to $37.79 3-Month Outlook: Projected fall of -10.31%, reaching $35.58 by June 20, 2024, with a range of $33.45 to $37.19. 1-Year Outlook: Projected gain of 51.47%, with price at $60.09 by March 21, 2025, within a range of $51.72 to $67.09.

Key Takeaways

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) shares are flat 1.85% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Apollo Medical Holdings, Inc. trading at a premium to the broader market with a P/E of 211.29. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $56.50, suggesting 42.43% upside. Our AI forecast model points to short-term weakness (-7.97% over two weeks), a medium-term fall (-10.31% over three months), and a longer-term gain (51.47% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Apollo Medical Holdings, Inc. (AMEH) stock price?

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) stock price is $40.82 in the last trading session. During the trading session, AMEH stock reached the peak price of $42.75 while $40.71 was the lowest point it dropped to. The percentage change in AMEH stock occurred in the recent session was -2.11% while the dollar amount for the price change in AMEH stock was - $0.88.

AMEH's industry and sector of operation?

The NASDAQ listed AMEH is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Apollo Medical Holdings, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AMEH?

Mr. Chandan Basho
Chief Strategy Officer, Interim Chief Financial Officer & Corporation Sec.
Dr. Thomas S. Lam M.D., M.P.H.
Pres, Co-Chief Executive Officer & Director
Mr. Neil Ahuja
Pres of Provider Solutions
Yubin Park
Chief Analytics Officer
Dr. WaiChow Young M.D.
Chief Admin. Officer
Mr. John Vong
Chief Accounting Officer
Mr. Chan Basho
Chief Strategy Officer & Interim Chief Financial Officer
Mr. Brandon Sim
Co-Chief Executive Officer
Dr. Jeremy R. Jackson M.D.
Chief Quality Officer
Dr. Carlos Palacios M.D.
Chief Medical Officer for Texas
Dr. Kenneth T. Sim M.D.
Executive Chairman

How AMEH did perform over past 52-week?

AMEH's closing price is 41.42% higher than its 52-week low of $28.87 where as its distance from 52-week high of $45.71 is -10.7%.

How many employees does AMEH have?

Number of AMEH employees currently stands at 1,362.

Link for AMEH official website?

Official Website of AMEH is: https://www.apollomed.net

How do I contact AMEH?

AMEH could be contacted at phone 626 282 0288 and can also be accessed through its website. AMEH operates from 1668 South Garfield Avenue, Alhambra, CA 91801, United States.

How many shares of AMEH are traded daily?

AMEH stock volume for the day was 313.94K shares. The average number of AMEH shares traded daily for last 3 months was 208.84K.

What is the market cap of AMEH currently?

The market value of AMEH currently stands at $1.83B with its latest stock price at $40.82 and 44.84M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1362
Beta	1.04
Sales or Revenue	$1.14B
5Y Sales Change%	0.878%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Care Facilities

AMEH Company Profile and Key Details

Apollo Medical

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook

Valuation Metrics